Servier

This study tests an experimental drug called vorasidenib in about 57 Asian patients with a slow-growing brain tumor (grade 2 glioma) that has a specific genetic mutation (IDH1 or IDH2). Half the participants get the drug, half get a placebo, and researchers track how long it take…

This study tests a daily oral drug called ivosidenib in 12 Japanese adults with advanced bile duct cancer that has a specific IDH1 gene mutation and has already been treated with chemotherapy. The goal is to see if the drug can stop or slow the cancer from growing. Participants t…